The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer

Chen Xia1, Hong Jiang2, Fugui Ye3

  • 1Department of Medical Oncology, Hepatobiliary and Pancreatic Unit, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, People's Republic of China.

Oncotargets and Therapy
|October 22, 2019
PubMed
Abstract

Insights

The miR-218-5p-Cx43 axis plays a key role in gemcitabine resistance in breast cancer. Understanding this axis offers potential for new therapeutic strategies against chemoresistant breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gemcitabine is a standard first-line treatment for breast cancer.
  • Mechanisms underlying gemcitabine resistance in breast cancer remain largely unknown.

Purpose of the Study:

  • To investigate the role of Connexin 43 (Cx43) in gemcitabine resistance.
  • To elucidate the epigenetic regulation of Cx43 and its involvement in breast cancer progression and chemoresistance.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot analyses were used to assess Cx43 expression.
  • Dual-luciferase reporter assays identified miR-218-5p as a direct regulator of Cx43.
  • In vitro experiments using mammalian expression vectors and small short RNA (shRNA) evaluated the functional impact of the miR-218-5p-Cx43 axis.

Main Results:

  • Cx43 expression was significantly lower in gemcitabine-resistant breast cancer cells compared to parental cells.
  • An inverse correlation was observed between miR-218-5p and Cx43 expression, establishing the miR-218-5p-Cx43 axis.
  • This axis was implicated in gemcitabine chemoresistance, cell proliferation, and migration.

Conclusions:

  • The miR-218-5p-Cx43 axis is a significant factor in breast cancer.
  • This axis holds potential for therapeutic and prognostic applications in translational medicine for breast cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K